Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test

Life Sciences

Volumn 80, Issue 16, 2007, Pages 1539-1543

  Li, Bingjin ^a   Suemaru, Katsuya ^a   Cui, Ranji ^a   Araki, Hiroaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain derived neurotrophic factor (BDNF); Electroconvulsive stimuli (ECS); Forced swim test

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; RAT; WITHDRAWAL REFLEX;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; ELECTROCONVULSIVE THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMOBILIZATION; LOCOMOTION; RATS; SWIMMING;

RATTUS;

EID: 33947096866     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.032     Document Type: Article

References (51)

1. Altar C.A. Neurotrophins and depression. Trends in Pharmacological Sciences 20 2 (1999) 59-61
2. Altar C.A., Boylan C.B., Jackson C., Hershenson S., Miller J., Wiegand S.J., Lindsay R.M., and Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proceedings of the National Academy of Sciences of the United States of America 89 23 (1992) 11347-11351
3. Altar C.A., Boylan C.B., Fritsche M., Jones B.E., Jackson C., Wiegand S.J., Lindsay R.M., and Hyman C. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. Journal of Neurochemistry 63 3 (1994) 1021-1032
4. Altar C.A., Whitehead R.E., Chen R., Wortwein G., and Madsen M.R. Effects of electroconvulsive seizure and antidepressants on BDNF protein in rat brain. Biological Psychiatry 54 7 (2003) 703-709
5. Artigas F., Perez V., and Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry 51 3 (1994) 248-251
6. Blier P., and Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. Journal of Clinical Psychopharmacology 15 3 (1995) 217-222
7. Bopaiah C.P., and Pradhan N. Central nervous system stimulatory action from the root extract of Plumbago zeylanica in rats. Phytotherapy Research 15 2 (2001) 153-156
8. Brimblecombe R.W., and Green A.L. Effect of monoamine oxidase inhibitors on the behavior of rats in Hall's open field. Nature 194 (1962) 983
9. Broderick P.A., Gardner E.L., and van Praag H.M. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion. Biological Psychiatry 19 1 (1984) 45-54
10. Chen A.C., Shin K.H., Duman R.S., and Sanacora G. ECS-induced mosy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. The Journal of ECT 17 1 (2001) 27-32
11. D'Aquila P.S., Collu M., Gessa G.L., and Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. European Journal of Pharmacology 405 1-3 (2000) 365-373
12. D'Aquila P.S., Peana A.T., Tanda O., and Serra G. Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole. European Journal of Pharmacology 416 1-2 (2001) 107-111
13. D'Aquila P.S., Peana A.T., Panin F., Grixoni C., Cossu M., and Serra G. Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal. European Journal of Pharmacology 458 1-2 (2003) 129-134
14. Dremencov E., Gur E., Lerer B., and Newman M.E. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 5 (2003) 729-739
15. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 54 7 (1997) 597-606
16. Duncan G.E., Breese G.R., Criswell H., Stumpf W.E., Mueller R.A., and Covey J.B. Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. Journal of Pharmacology and Experimental Therapeutics 238 2 (1986) 758-762
17. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., and Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 60 8 (2003) 804-815
18. Fukumoto T., Morinobu S., Okamoto Y., Kagaya A., and Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158 1 (2001) 100-106
19. Gulati A., Srimal R.C., Dhawan K.N., and Dhawan B.N. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock. Neuropharmacology 26 12 (1987) 1733-1737
20. Hirschfeld R.M. Antidepressants in long-term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica. Supplementum 403 (2000) 35-38
21. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., and Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. The Journal of Neuroscience 19 10 (1999) 4110-4122
22. Hoshaw B.A., Malberg J.E., and Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research 1037 1-2 (2005) 204-208
23. Jacobsen J.P., and Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Research 1024 1-2 (2004) 183-192
24. Katz M.M., Tekell J.L., Bowden C.L., Brannan S., Houston J.P., Berman N., and Frazer A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 29 3 (2004) 566-579
25. Kawashima K., Araki H., Uchiyama Y., and Aihara H. Amygdaloid catecholaminergic mechanisms involved in suppressive effects of electroconvulsive shock on duration of immobility in rats forced to swim. European Journal of Pharmacology 141 1 (1987) 1-6
26. Keller M.B. The long-term treatment of depression. The Journal of Clinical Psychiatry 17 (1999) 41-48
27. Li B., Suemaru K., Cui R., Kitamura Y., Gomita Y., and Araki H. Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats. European Journal of Pharmacology 529 1-3 (2006) 114-121
28. Luthman J., Lindqvist E., and Ogren S.O. Hyperactivity in neonatally dopamine-lesioned rats requires residual activity in mesolimbic dopamine neurons. Pharmacology, Biochemistry and Behavior 51 1 (1995) 159-163
29. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience 20 24 (2000) 9104-9110
30. Markowitz J., Brown R., Sweeney J., and Mann J.J. Reduced length and cost of hospital stay for major depression in patients treated with ECT. The American Journal of Psychiatry 144 8 (1987) 1025-1029
31. Martin-Iverson M.T., Todd K.G., and Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. The Journal of Neuroscience 14 (1994) 1262-1270
32. Naert G., Ixart G., Tapia-Arancibia L., and Givalois L. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats. Neuroscience 139 2 (2006) 779-789
33. Narita M., Aoki K., Takagi M., Yajima Y., and Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119 3 (2003) 767-775
34. Nibuya M., Morinobu S., and Duman R. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. The Journal of Neuroscience 15 11 (1995) 7539-7547
35. Pencea V., Bingaman K.D., Wiegand S.J., and Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. The Journal of Neuroscience 21 17 (2001) 6706-6717
36. Pettinati H.M., Tamburello T.A., and Ruetsch C.R. Patient attitudes toward electroconvulsive therapy. Psychopharmacology Bulletin 30 3 (1994) 471-475
37. Porsolt R.D., Le Pichor M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 5604 (1977) 730-732
38. Serra G., Collu M., D'Aquila P.S., De Montis G.M., and Gessa G.L. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Research 527 2 (1990) 234-243
39. Serra G., Collu M., D'Aquila P.S., and Gessa G.L. Role of the mesolimbic dopamine system in the mechanism of action of antidepressants. Pharmacology and Toxicology 71 (1992) 72-85
40. Schaaf M.J., de Jong J., de Kloet E.R., and Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Research 813 1 (1998) 112-120
41. Schinder A.F., and Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends in Neurosciences 23 12 (2000) 639-645
42. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrohic factor produces antidepressant effects in behavioral models of depression. The Journal of Neuroscience 22 8 (2002) 3251-3261
43. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., and Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Research 710 1-2 (1996) 11-20
44. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology, Biochemistry and Behavior 56 1 (1997) 131-137
45. Smith S.E., and Sharp T. Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like dopamine receptors. Psychopharmacology (Berlin) 133 1 (1997) 77-84
46. Suzuki M., and Masuda Y. Effect of repeated electroconvulsive shock treatment on a depression model, mouse forced swimming. The Tohoku Journal of Experimental Medicine 189 1 (1999) 83-86
47. Thoenen H. Neurotrophins and neuronal plasticity. Science 270 5236 (1995) 593-598
48. Vaidya V.A., Siucia J.A., Du F., and Duman R.S. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89 1 (1999) 157-166
49. Weiner R.D. Electroconvulsive therapy. In: Kaplan H.I., and Sadock B.J. (Eds). Comprehensive Textbook of Psychiatry (1989), Williams & Wilkins., Baltimore 1670-1680
50. Zarrindast M.R., Sahebgharani M., and Burnham W.M. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test. European Neuropsychopharmacology 14 6 (2004) 509-514
51. Zigova T., Pencea V., Wiegand S.J., and Luskin M.B. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Molecular and Cellular Neurosciences 11 4 (1998) 234-245